$2.17

0.13 (5.65%)

Buy
below
Hold
up to
Sell
above
Buy Hold Sell Meter
Locked Recommendation

Analysis

Overview

Current recommendation
Business risk 0
Share price risk 0

General Information

Mesoblast Limited
MSB
http://www.mesoblast.com
Biotechnology
828
381

Current Price Data+

Current Price $2.170
Open $2.240
High $2.260
Low $2.170
Last Close $2.300
Volume 698540
Price Movement $0.13 ( 5.65% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Stock Price

Current Broker Consensus Recommendation

Buy
2 May 2016
2

Company Overview

Business Description

Mesoblast Limited (MSB) is an Australian company engaging in the development of biologic products for regenerative medicine. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells. Its intellectual property covers a range of applications in key markets including the United States, Europe, Japan and China.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2017 F -134.3 -30.1 0.0% -7.2 0.0 0.0% 0.0%
2016 F -131.2 -36.5 0.0% -5.9 0.0 0.0% 0.0%
2015 A -148.6 -46.3 0.0% -8.9 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2015 A 2016 F 2017 F 2015 A 2016 F 2017 F 2015 A 2016 F 2017 F
Bionomics (BNO) $159M 0.0000 0.0000 0.0000 0.0000 0.0000 3.4773 0.00% 0.00% 0.00%
CSL (CSL) $50,118M 0.3109 0.0440 0.2597 29.2264 27.9959 22.2247 1.48% 1.53% 2.33%
Mesoblast (MSB) $877M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $437M 1.8016 0.1736 0.0347 17.9922 15.3306 14.8163 3.75% 4.57% 4.73%
Sirtex Medical (SRX) $1,720M 0.6876 0.4570 0.4487 43.0846 29.5716 20.4119 0.67% 0.99% 1.43%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.19 0.00
Market 1.04 16.30 1.29 1.53
Sector 0.49 15.70 3.30 0.71

Directors

Name Position Start Date
Professor Silviu Itescu Chief Executive Officer, Executive Director 8 Jun 2004
Mr Brian Jamieson Non-Executive Chairman 22 Nov 2007
Mr Michael Robert Spooner Non-Executive Director 29 Sep 2004
Mr Donal O'Dwyer Non-Executive Director 29 Sep 2004
Dr Ben-Zion Weiner Non-Executive Director 9 May 2012
Dr Eric A Rose Non-Executive Director 15 Apr 2013
Mr William M Burns Non-Executive Director 6 Mar 2014

Management

Name Position
Paul Hodgkinson Chief Financial Officer
Charlie Harrison Company Secretary

Substantial Shareholders

Holding Name
68,244,642 (20.46%) Silviu Itescu
55,785,806 (16.73%) Cephalon International Holdings Inc
38,717,697 (11.61%) M&G Investment Funds
26,600,000 (7.98%) The Capital Group Companies, Inc.
19,004,000 (5.70%) Thorney Opportunities Ltd

Calendar of Events

Date Event
15 February 2017 Report (Interim)
19 September 2016 Report (Annual)
15 August 2016 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.